2018
DOI: 10.1177/1479164118793986
|View full text |Cite
|
Sign up to set email alerts
|

Impact of diabetes type on treatment and outcome of patients with peripheral artery disease

Abstract: Background: The prevalence of diabetes mellitus and its associated complications such as peripheral artery disease is increasing worldwide. We aimed to explore the distinct impact of type 1 diabetes mellitus and type 2 diabetes mellitus on treatment and on short-and long-term outcome in patients with peripheral artery disease. Methods: Retrospective analysis of anonymized data of hospitalized patients covered by a large German health insurance. Assessment of patient's characteristics (comorbidities, complicati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
13
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 16 publications
2
13
0
1
Order By: Relevance
“…However, it is important to identify PAD in patients with diabetic foot ulceration (DFU) at the earliest possible stage, as the presence of PAD is associated with increased risk of nonhealing ulcers, infection, and major limb amputation, as well as an elevated risk of cardiovascular morbidity and overall mortality. [10][11][12][13][14] The prognosis of a patient with diabetes, PAD, and foot ulceration requiring amputation is worse than many common cancers-up to 50% of patients will not survive 5 years. 4,15 There are several guidelines for the management of patients with PAD and chronic limb-threatening ischaemia (CLTI).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, it is important to identify PAD in patients with diabetic foot ulceration (DFU) at the earliest possible stage, as the presence of PAD is associated with increased risk of nonhealing ulcers, infection, and major limb amputation, as well as an elevated risk of cardiovascular morbidity and overall mortality. [10][11][12][13][14] The prognosis of a patient with diabetes, PAD, and foot ulceration requiring amputation is worse than many common cancers-up to 50% of patients will not survive 5 years. 4,15 There are several guidelines for the management of patients with PAD and chronic limb-threatening ischaemia (CLTI).…”
Section: Introductionmentioning
confidence: 99%
“…Diagnostic tests may be less reliable due to the presence of peripheral neuropathy, medial arterial calcification, and peripheral oedema. However, it is important to identify PAD in patients with diabetic foot ulceration (DFU) at the earliest possible stage, as the presence of PAD is associated with increased risk of nonhealing ulcers, infection, and major limb amputation, as well as an elevated risk of cardiovascular morbidity and overall mortality . The prognosis of a patient with diabetes, PAD, and foot ulceration requiring amputation is worse than many common cancers—up to 50% of patients will not survive 5 years …”
Section: Introductionmentioning
confidence: 99%
“…The combination of diabetes and PAD substantially increases the risk of amputation or non‐healing and of cardiovascular mortality . In the Eurodiale study, patients with a foot ulcer and PAD, when compared with ulcer patients without PAD, had healing rates of 69% vs 84% and major amputation rates of 8% vs 2%, respectively .…”
Section: Introductionmentioning
confidence: 99%
“…5 The combination of diabetes and PAD substantially increases the risk of amputation or non-healing and of cardiovascular mortality. [6][7][8] In the Eurodiale study, patients with a foot ulcer and PAD, when compared with ulcer patients without PAD, had healing rates of 69% vs 84% and major amputation rates of 8% vs 2%, respectively. 2 Not only is PAD an independent risk factor for developing foot ulceration and limb loss, it is also associated with a higher risk of incident cardiovascular disease and of overall mortality, irrespective of symptoms or the populations studied.…”
mentioning
confidence: 99%
“…In Germany, researchers have shown a high prevalence and higher risk of PAD among type 1 diabetic elderly patients with a mean age of 62.6 years and in type 2 DM with a mean age of 71.3 years (p < 0.0001), probably related to a longer disease course [40].…”
Section: Dm-related Amputationsmentioning
confidence: 99%